peptideallianceStandard v1.1

Seller record · telehealth service · oaklovesyou.com

Oak

A telehealth weight-loss service selling compounded semaglutide and tirzepatide. It discloses no United States business address, and it names no filling pharmacy.

Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1, August 2026.

Dispositions at a glance

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSThe site states every prescription is reviewed by a board-certified provider.Source: oaklovesyou.com · read August 2026.
S2PASSA qualification step and physician review precede any prescription.Source: oaklovesyou.com/weight-loss · read August 2026.
S3FAILOrders are fulfilled through licensed US compounding pharmacies; none is named.Source: oaklovesyou.com · read August 2026.
S4PASSStates plainly that compounded drugs are not FDA-approved as finished products.Source: oaklovesyou.com/product · read August 2026.
S5NOT VERIFIEDThis check has not been performed for this seller as of August 2026.
S6FAILNo US street address on any page read; the privacy policy is written for Canada.Source: oaklovesyou.com/privacy-policy · read August 2026.
S7PASSPrices printed on public pages: programs from $119 monthly.Source: oaklovesyou.com · read August 2026.
S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, tirzepatide, NAD+, glutathione, sermorelin, tadalafil.

Visit OakPartner link. The site earns a commission on care started through it. Funding.

Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.